PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SKT | Ann: Sky and BBC Studios renew expanded, multi-year agreement | 07:20 | 0 | 19 | |||
|
|||||||
SKT | Ann: On-market Share Buyback | 06:50 | 0 | 40 | |||
|
|||||||
SKT | Ann: On-market Share Buyback | 22/04/24 | 0 | 34 | |||
|
|||||||
SKT | Ann: On-market Share Buyback | 19/04/24 | 0 | 35 | |||
|
|||||||
SKT | Ann: On-market Share Buyback | 18/04/24 | 0 | 59 | |||
|
|||||||
SKT | Ann: On-market Share Buyback | 17/04/24 | 0 | 28 | |||
|
|||||||
SKT | Ann: On-market Share Buyback | 16/04/24 | 0 | 39 | |||
|
|||||||
SKT | Ann: On-market Share Buyback | 15/04/24 | 0 | 54 | |||
|
See All Discussions